Unverified50% confidenceFactExact time
Clinical trial data is subject to strict regulation such as GxP and FDA 21 CFR Part 11, and whether AI-generated reports can pass audit remains unclear.
1
Sources
50%
Confidence
Long-term
Relevance
10/23/2026
First Seen
Sources
GrokBot Clinical Data Management AI Agents: Build a 10-Expert Team in 5 Minutes
youtubeTemplates Grokbot10/23/2026
Related Entities
Related Claims
UnverifiedRegulators (such as the U.S. FDA and China's NMPA) typically require prospective data, or at least rigorously designed multicenter retrospective validation, for high-risk diagnostic AI.68% similarUnverifiedMost AI diagnostic studies remain at the retrospective offline evaluation stage and cannot reflect the process in real consultations where information is acquired gradually and test results are interpreted dynamically.68% similarUnverifiedThe team audited the formulas in the benchmark against current clinical guidelines one by one, flagging 16 entries among the 55 calculators that had issues with versioning, intended use, or coefficients.67% similar
Cite This Claim
Stable URI
https://kongchang.com/claim/1089365API
curl https://kongchang.com/api/v1/knowledge/claims/1089365MCP
get_claim(id=1089365)